News Shire tipped as next big pharma takeover target After trial failure, shares rallied on takeover rumours
News Shire's Hunter Syndrome cognitive impairment drug fails Trial missed primary and secondary endpoints
News Shire CEO backs outcomes-based deals in rare diseases Strategy could help make rare disease drugs affordable
News Judge throws out Allergan patents, criticises Native America... Federal court throws out patents on Restasis
News Intercept shares dive after FDA safety alert on liver drug Regulator warns of death risk in patients on higher than recommended dose.
Partner Content Partner Content 5 Key Reasons Why You Should Attend Europe's Leading Ophthal... 5 Key Reasons Why You Should Attend
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
